Wednesday, September 23, 2026

HomeHealth News'Plug-and-play' CAR T technology adapts as cancer changes

‘Plug-and-play’ CAR T technology adapts as cancer changes

- Advertisement -

Researchers from City of Hope have developed a new “plug-and-play” technology that adds engineered molecules to chimeric antigen receptor (CAR) T cells after treatment, allowing scientists to better control the cells and redirect them to attack different types of cancer. Credit: City of Hope

Researchers from City of Hope have developed a new “plug-and-play” technology that adds engineered…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed